首页 > 最新文献

BMJ Surgery Interventions Health Technologies最新文献

英文 中文
Understanding and quantifying the environmental impact of sterile medical devices: a carbon footprint study of single-use electrosurgical scalpels and their reusable alternatives. 了解和量化无菌医疗器械对环境的影响:一次性电外科手术刀及其可重复使用替代品的碳足迹研究。
IF 2.1 Q2 SURGERY Pub Date : 2025-07-03 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2024-000348
Annabel Goubil, Kimberley Lefèvre, Chloé Couret, Mireille Ferlita, David Feldman, Johann Clouet, Elise Rochais

Abstract:

Background: In France, 25% of healthcare emissions are attributed to the supply of medical devices, underscoring the necessity for the development of more sustainable procurement policies. However, comparing the carbon footprint of different devices, especially single-use devices versus reusable ones, presents challenges.

Objective: To assess the carbon footprint of single-use and reusable electrosurgical scalpels over 1 year of use in our hospital setting.

Design: A cradle-to-grave analysis was conducted from May 1, 2022, to April 30, 2023.

Setting: Nantes University Hospital, France.

Main outcome measures: The study quantifies carbon emissions across all life cycle stages: raw material extraction, manufacturing, transportation, use, maintenance, and disposal. For reusable devices, sterilization emissions were allocated based on the total annual workload of the Central Sterile Services Department. Carbon footprint values were derived from direct measurements, manufacturer and supplier data, and literature, with conversions using a public and national database (Base Empreinte, ADEME).

Results: The carbon footprint of single-use devices was estimated at 4291 kg of carbon dioxide equivalent (CO2e), with 94% attributed to the production of the device itself. The carbon footprint related to the reusable device was estimated at 494 kg CO2e, with 86% stemming from handling at our sterilization unit.

Conclusions: These findings are contingent on our hospital's practices and may vary based on several factors. Beyond estimating these carbon footprints, it provides a practical, decision-oriented analysis accessible for hospital leadership and healthcare professionals, supporting institutional change.

摘要:背景:在法国,25%的医疗保健排放归因于医疗设备的供应,强调了制定更可持续采购政策的必要性。然而,比较不同设备的碳足迹,尤其是一次性设备与可重复使用设备的碳足迹,会带来挑战。目的:评估我院使用1年以上的一次性和可重复使用电刀的碳足迹。设计:从2022年5月1日至2023年4月30日进行了从摇篮到坟墓的分析。地点:法国南特大学医院。主要结果测量:该研究量化了所有生命周期阶段的碳排放:原材料开采、制造、运输、使用、维护和处置。对于可重复使用的器械,消毒排放是根据中央消毒服务部每年的总工作量来分配的。碳足迹值来自直接测量、制造商和供应商数据以及文献,并使用公共和国家数据库(Base Empreinte, ADEME)进行转换。结果:一次性使用设备的碳足迹估计为4291千克二氧化碳当量(CO2e),其中94%归因于设备本身的生产。与可重复使用的设备相关的碳足迹估计为494公斤二氧化碳当量,其中86%来自我们消毒部门的处理。结论:这些发现取决于我们医院的实践,并可能因几个因素而有所不同。除了估算这些碳足迹之外,它还为医院领导和医疗保健专业人员提供了实用的、面向决策的分析,支持制度变革。
{"title":"Understanding and quantifying the environmental impact of sterile medical devices: a carbon footprint study of single-use electrosurgical scalpels and their reusable alternatives.","authors":"Annabel Goubil, Kimberley Lefèvre, Chloé Couret, Mireille Ferlita, David Feldman, Johann Clouet, Elise Rochais","doi":"10.1136/bmjsit-2024-000348","DOIUrl":"10.1136/bmjsit-2024-000348","url":null,"abstract":"<p><strong>Abstract: </strong></p><p><strong>Background: </strong>In France, 25% of healthcare emissions are attributed to the supply of medical devices, underscoring the necessity for the development of more sustainable procurement policies. However, comparing the carbon footprint of different devices, especially single-use devices versus reusable ones, presents challenges.</p><p><strong>Objective: </strong>To assess the carbon footprint of single-use and reusable electrosurgical scalpels over 1 year of use in our hospital setting.</p><p><strong>Design: </strong>A cradle-to-grave analysis was conducted from May 1, 2022, to April 30, 2023.</p><p><strong>Setting: </strong>Nantes University Hospital, France.</p><p><strong>Main outcome measures: </strong>The study quantifies carbon emissions across all life cycle stages: raw material extraction, manufacturing, transportation, use, maintenance, and disposal. For reusable devices, sterilization emissions were allocated based on the total annual workload of the Central Sterile Services Department. Carbon footprint values were derived from direct measurements, manufacturer and supplier data, and literature, with conversions using a public and national database (Base Empreinte, ADEME).</p><p><strong>Results: </strong>The carbon footprint of single-use devices was estimated at 4291 kg of carbon dioxide equivalent (CO<sub>2</sub>e), with 94% attributed to the production of the device itself. The carbon footprint related to the reusable device was estimated at 494 kg CO<sub>2</sub>e, with 86% stemming from handling at our sterilization unit.</p><p><strong>Conclusions: </strong>These findings are contingent on our hospital's practices and may vary based on several factors. Beyond estimating these carbon footprints, it provides a practical, decision-oriented analysis accessible for hospital leadership and healthcare professionals, supporting institutional change.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000348"},"PeriodicalIF":2.1,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12226936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neural network models for predicting readmission among patients undergoing peripheral vascular intervention using electronic health record data and clinical registry data. 利用电子健康记录数据和临床登记数据预测外周血管干预患者再入院的神经网络模型。
IF 1.6 Q2 SURGERY Pub Date : 2025-06-26 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2025-000387
Jialin Mao, Philip Goodney, Samprit Banerjee, Zoran Kostic, Kim Smolderen, Carlos Mena-Hurtado, Michael E Matheny

Objectives: To determine whether neural network models based on electronic health record (EHR) data can match and augment the performance of models based on clinical registry data in predicting readmission after peripheral vascular intervention (PVI).

Design: Observational cohort study.

Setting: Vascular Quality Initiative registry and INSIGHT Clinical Research Network EHR data from multiple academic institutions in New York City.

Participants: Patients undergoing PVI during January 1, 2013 to September 30, 2021.

Main outcome measures: Our outcome variable was 90-day readmission. We developed logistic regression (LR), multilevel perceptron (MLP), and recurrent neural network (RNN) models using registry alone, EHR data alone, and combined registry-EHR data. EHR data were evaluated using derived variables to match registry variables (EHR-derived data) and clinically meaningful code aggregation (EHR-direct data). Models were evaluated using area under the curve (AUC) for discrimination, Spiegelhalter z score for calibration, and Brier score for overall performance.

Results: The analytical cohort included 2348 patients undergoing PVI (mean age: 69.9±11.5 years). 832 (35%) patients were readmitted within 90 days. LR to predict 90-day readmission based on registry data alone had an AUC of 0.710, Spiegelhalter z score of 1.021, and Brier score of 0.211. MLP based on registry data alone had similar performance. MLP and RNN based on EHR-direct data (MLP: AUC=0.742, Spiegelhalter z=0.933, Brier=0.204; RNN: AUC=0.737, Spiegelhalter z=1.026, Brier=0.206) and registry+EHR-direct data (MLP: AUC=0.756, Spiegelhalter z=0.794, Brier=0.199; RNN: AUC=0.751, Spiegelhalter z=1.057, Brier=0.200) had improved performances. LR based on EHR-direct data and combined registry+EHR-direct data had worse performances.

Conclusions: EHR data, when used with neural network models, can be useful to establish readmission predictive models or augment clinical registry data. EHR-based models can be potentially embedded in the clinical workflow, but model performance may be constrained by the absence of certain information in clinical encounters, such as social determinants of health.

目的:确定基于电子健康记录(EHR)数据的神经网络模型是否可以匹配并增强基于临床注册数据的模型在预测外周血管干预(PVI)后再入院方面的表现。设计:观察性队列研究。环境:来自纽约市多个学术机构的血管质量倡议注册表和INSIGHT临床研究网络电子病历数据。参与者:2013年1月1日至2021年9月30日期间接受PVI治疗的患者。主要结局指标:我们的结局变量为90天再入院。我们开发了逻辑回归(LR)、多层感知器(MLP)和循环神经网络(RNN)模型,分别使用单独的注册表数据、单独的电子病历数据以及注册表-电子病历数据的组合。使用衍生变量来评估EHR数据,以匹配注册变量(EHR衍生数据)和临床有意义的代码聚合(EHR直接数据)。使用曲线下面积(AUC)进行判别,Spiegelhalter z评分进行校准,Brier评分进行总体性能评估。结果:分析队列包括2348例PVI患者(平均年龄:69.9±11.5岁)。832例(35%)患者在90天内再次入院。仅基于注册表数据预测90天再入院的LR AUC为0.710,Spiegelhalter z评分为1.021,Brier评分为0.211。仅基于注册表数据的MLP具有类似的性能。基于EHR-direct数据的MLP和RNN (MLP: AUC=0.742, Spiegelhalter z=0.933, Brier=0.204;RNN: AUC=0.737, Spiegelhalter z=1.026, Brier=0.206)和注册表+EHR-direct数据(MLP: AUC=0.756, Spiegelhalter z=0.794, Brier=0.199;RNN: AUC=0.751, Spiegelhalter z=1.057, Brier=0.200)提高了性能。基于EHR-direct数据和结合注册表+EHR-direct数据的LR表现较差。结论:当电子病历数据与神经网络模型结合使用时,可用于建立再入院预测模型或增加临床登记数据。基于电子病历的模型可以潜在地嵌入到临床工作流程中,但模型的性能可能会受到临床接触中缺乏某些信息(如健康的社会决定因素)的限制。
{"title":"Neural network models for predicting readmission among patients undergoing peripheral vascular intervention using electronic health record data and clinical registry data.","authors":"Jialin Mao, Philip Goodney, Samprit Banerjee, Zoran Kostic, Kim Smolderen, Carlos Mena-Hurtado, Michael E Matheny","doi":"10.1136/bmjsit-2025-000387","DOIUrl":"10.1136/bmjsit-2025-000387","url":null,"abstract":"<p><strong>Objectives: </strong>To determine whether neural network models based on electronic health record (EHR) data can match and augment the performance of models based on clinical registry data in predicting readmission after peripheral vascular intervention (PVI).</p><p><strong>Design: </strong>Observational cohort study.</p><p><strong>Setting: </strong>Vascular Quality Initiative registry and INSIGHT Clinical Research Network EHR data from multiple academic institutions in New York City.</p><p><strong>Participants: </strong>Patients undergoing PVI during January 1, 2013 to September 30, 2021.</p><p><strong>Main outcome measures: </strong>Our outcome variable was 90-day readmission. We developed logistic regression (LR), multilevel perceptron (MLP), and recurrent neural network (RNN) models using registry alone, EHR data alone, and combined registry-EHR data. EHR data were evaluated using derived variables to match registry variables (EHR-derived data) and clinically meaningful code aggregation (EHR-direct data). Models were evaluated using area under the curve (AUC) for discrimination, Spiegelhalter z score for calibration, and Brier score for overall performance.</p><p><strong>Results: </strong>The analytical cohort included 2348 patients undergoing PVI (mean age: 69.9±11.5 years). 832 (35%) patients were readmitted within 90 days. LR to predict 90-day readmission based on registry data alone had an AUC of 0.710, Spiegelhalter z score of 1.021, and Brier score of 0.211. MLP based on registry data alone had similar performance. MLP and RNN based on EHR-direct data (MLP: AUC=0.742, Spiegelhalter z=0.933, Brier=0.204; RNN: AUC=0.737, Spiegelhalter z=1.026, Brier=0.206) and registry+EHR-direct data (MLP: AUC=0.756, Spiegelhalter z=0.794, Brier=0.199; RNN: AUC=0.751, Spiegelhalter z=1.057, Brier=0.200) had improved performances. LR based on EHR-direct data and combined registry+EHR-direct data had worse performances.</p><p><strong>Conclusions: </strong>EHR data, when used with neural network models, can be useful to establish readmission predictive models or augment clinical registry data. EHR-based models can be potentially embedded in the clinical workflow, but model performance may be constrained by the absence of certain information in clinical encounters, such as social determinants of health.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000387"},"PeriodicalIF":1.6,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12207173/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel approach to meniscal vascularity evaluation using indocyanine green fluorescence-guided knee arthroscopy. 用吲哚菁绿荧光引导膝关节镜评估半月板血管的新方法。
IF 2.1 Q2 SURGERY Pub Date : 2025-06-25 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2024-000351
Tamiko Kamimura

Objectives: This study aimed to use indocyanine green (ICG) fluorescence-guided knee arthroscopy to observe the meniscus and surrounding tissue vascularity and determine correlation with the patients' backgrounds. Currently, no data are available on the clinical application of ICG fluorescence-guided knee arthroscopy in assessing meniscal vascularity.

Design: Prospective, case series.

Setting: In-hospital settings.

Participants: 41 knees of 34 patients were examined. 4 knees of 4 patients were included in a pilot study for technique refinement only, while the remaining 37 knees of 30 patients were included in the study.

Main outcome measures: The times from ICG administration to fluorescence onset and fluorescence duration from onset to complete attenuation were recorded. The fluorescence intensity at the anterior, middle, and posterior segments of the meniscus was evaluated on a 4-point scale. The younger and older and smoker and non-smoker groups were compared.

Results: The average fluorescence onset time was 32.05 s, whereas the average fluorescence duration was 11 min 14 s. The age groups aged≤45 and ≥46 years showed an onset of 30±24.9 and 33.17±16.2 s and a duration of 12 min 54 s and 10 min 20 s, respectively. The smoking and non-smoking groups exhibited an onset of 28.33±14.4 and 33.84±21.5 s and a duration of 10 min 37 s and 11 min 32 s, respectively. All segments of the lateral meniscus showed higher fluorescence intensities than the medial. The posterior segment of the lateral meniscus at ≤45 was markedly more fluorescent and significantly different from ≥46.

Conclusions: Fluorescence was observed for approximately 30 s after intravenous ICG injection and lasted approximately 10 min. Fluorescence intensity was brighter in the posterior segment of the lateral meniscus, particularly at ≤45. ICG fluorescence-guided knee arthroscopy may assist in case-specific hemodynamics and real-time surgical evaluation of the meniscus in living humans.

目的:本研究旨在利用吲哚菁绿(ICG)荧光引导下的膝关节镜观察半月板及周围组织的血管状况,并确定其与患者背景的相关性。目前,还没有关于ICG荧光引导膝关节镜在评估半月板血管的临床应用的数据。设计:前瞻性,案例系列。设置:医院设置。参与者:对34例患者的41个膝关节进行了检查。4例患者的4个膝关节被纳入一项仅用于技术改进的先导研究,而其余30例患者的37个膝关节被纳入研究。主要观察指标:记录ICG给药至荧光出现的时间和荧光出现至完全衰减的持续时间。在半月板的前、中、后段的荧光强度以4分制进行评估。对年轻人和老年人以及吸烟者和不吸烟者进行比较。结果:平均荧光起始时间为32.05 s,平均荧光持续时间为11 min 14 s。≤45岁和≥46岁年龄组发病时间分别为30±24.9和33.17±16.2 s,持续时间分别为12 min 54 s和10 min 20 s。吸烟组和非吸烟组发病时间分别为28.33±14.4和33.84±21.5 s,持续时间分别为10 min 37 s和11 min 32 s。外侧半月板各节段荧光强度均高于内侧半月板。≤45时外侧半月板后段荧光度明显高于≥46时。结论:静脉注射ICG后荧光持续时间约30 s,持续时间约10 min。荧光强度在外侧半月板后段更亮,特别是≤45。ICG荧光引导膝关节镜可能有助于病例特异性血流动力学和活体半月板的实时手术评估。
{"title":"Novel approach to meniscal vascularity evaluation using indocyanine green fluorescence-guided knee arthroscopy.","authors":"Tamiko Kamimura","doi":"10.1136/bmjsit-2024-000351","DOIUrl":"10.1136/bmjsit-2024-000351","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to use indocyanine green (ICG) fluorescence-guided knee arthroscopy to observe the meniscus and surrounding tissue vascularity and determine correlation with the patients' backgrounds. Currently, no data are available on the clinical application of ICG fluorescence-guided knee arthroscopy in assessing meniscal vascularity.</p><p><strong>Design: </strong>Prospective, case series.</p><p><strong>Setting: </strong>In-hospital settings.</p><p><strong>Participants: </strong>41 knees of 34 patients were examined. 4 knees of 4 patients were included in a pilot study for technique refinement only, while the remaining 37 knees of 30 patients were included in the study.</p><p><strong>Main outcome measures: </strong>The times from ICG administration to fluorescence onset and fluorescence duration from onset to complete attenuation were recorded. The fluorescence intensity at the anterior, middle, and posterior segments of the meniscus was evaluated on a 4-point scale. The younger and older and smoker and non-smoker groups were compared.</p><p><strong>Results: </strong>The average fluorescence onset time was 32.05 s, whereas the average fluorescence duration was 11 min 14 s. The age groups aged≤45 and ≥46 years showed an onset of 30±24.9 and 33.17±16.2 s and a duration of 12 min 54 s and 10 min 20 s, respectively. The smoking and non-smoking groups exhibited an onset of 28.33±14.4 and 33.84±21.5 s and a duration of 10 min 37 s and 11 min 32 s, respectively. All segments of the lateral meniscus showed higher fluorescence intensities than the medial. The posterior segment of the lateral meniscus at ≤45 was markedly more fluorescent and significantly different from ≥46.</p><p><strong>Conclusions: </strong>Fluorescence was observed for approximately 30 s after intravenous ICG injection and lasted approximately 10 min. Fluorescence intensity was brighter in the posterior segment of the lateral meniscus, particularly at ≤45. ICG fluorescence-guided knee arthroscopy may assist in case-specific hemodynamics and real-time surgical evaluation of the meniscus in living humans.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000351"},"PeriodicalIF":2.1,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12198815/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Factors associated with symptom-to-surgery time in patients undergoing surgical repair for acute type A aortic dissection: an exploratory analysis from a prospective cohort study. 更正:急性A型主动脉夹层手术修复患者从症状到手术时间的相关因素:一项前瞻性队列研究的探索性分析
IF 2.1 Q2 SURGERY Pub Date : 2025-06-22 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2024-000304corr1

[This corrects the article DOI: 10.1136/bmjsit-2024-000304.].

[更正文章DOI: 10.1136/bmjsit-2024-000304]。
{"title":"Correction: Factors associated with symptom-to-surgery time in patients undergoing surgical repair for acute type A aortic dissection: an exploratory analysis from a prospective cohort study.","authors":"","doi":"10.1136/bmjsit-2024-000304corr1","DOIUrl":"https://doi.org/10.1136/bmjsit-2024-000304corr1","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1136/bmjsit-2024-000304.].</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000304corr1"},"PeriodicalIF":2.1,"publicationDate":"2025-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144477098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of indocyanine green to look for vascularity of the pancreatic stump during Whipple's procedure and its clinical implications in terms of post-pancreatectomy acute pancreatitis and postoperative pancreatic fistula. 吲哚菁绿在Whipple手术中寻找胰腺残端血管的作用及其在胰腺切除术后急性胰腺炎和术后胰瘘中的临床意义
IF 2.1 Q2 SURGERY Pub Date : 2025-06-12 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2024-000318
Dhiresh Kumar Maharjan, Prabir Maharjan, Yugal Limbu, Roshan Ghimire, Prabin Bikram Thapa

Objectives: Post-pancreatectomy acute pancreatitis (PPAP) has been a well-defined entity by the International Study Group of Pancreatic Surgery. Underlying cause may be hypoperfusion at remnant stump of pancreas, which has been linked with additional post-pancreatectomy complications like postoperative pancreatic fistula. The primary goal was to assess the vascularity of remnant pancreas utilizing indocyanine green with near-infrared fluorescence. Indocyanine Green could aid in objectively mitigating hypoperfusion status of the pancreatic stump.

Design: Hospital-based descriptive study conducted as per the revised Strengthening the Reporting of Observational Studies in Epidemiology guidelines between 1 August 2022 and 2 August 2023.

Setting: This study was conducted in tertiary care centers of Kathmandu.

Participants: All 43 participants who underwent pancreaticoduodenectomies were included who completed the study.

Intervention: Blood supply to the remnant of the pancreas during pancreaticoduodenectomy was assessed utilizing indocyanine green, capturing distinct arterial, venous, and port venous phases, which were analyzed after 10 to 15 s of administration.

Main outcome measures: In three instances, indocyanine green dye revealed unequal vascular supply at the pancreatic remnant, requiring adjustments to the margins before completing the anastomosis of the remnant pancreas and the jejunum.

Results: PPAP was noticed in eight patients (18.6%), among which five patients (11.6 %) had postoperative hyperamylasemia, and three had grade B PPAP. The outcomes revealed that in the 40 patients with adequate perfusion, PPAP occurred in seven patients(16.3%), and grade B clinically relevant postoperative pancreatic fistula occurred in one patient. In contrast, among the three patients with inadequate perfusion, after revision of the pancreatic margin, PPAP was observed in one patient, and none of them had clinically relevant post-operative pancreatic fistula.

Conclusion: Postoperative acute pancreatitis, ultimately exhibiting the possibility of postoperative pancreatic fistula, must be monitored with vigilance. While several elements contribute to fistula formation, ensuring sufficient vascular supply at the pancreatic remnant using indocyanine green may alleviate presumed PPAP and associated complications. The dye could aid in enhancing surgical outcomes following pancreaticoduodenectomy.

目的:胰腺切除术后急性胰腺炎(PPAP)已被国际胰腺外科研究小组定义为一个明确的实体。潜在的原因可能是胰腺残端灌流不足,这与胰腺切除术后其他并发症如术后胰瘘有关。主要目的是利用近红外荧光吲哚菁绿评估残余胰腺的血管性。吲哚菁绿可以帮助客观上减轻胰腺残端灌注不足的状况。设计:在2022年8月1日至2023年8月2日期间,根据修订的加强流行病学观察性研究报告指南进行的基于医院的描述性研究。环境:本研究在加德满都的三级保健中心进行。参与者:所有43名接受胰十二指肠切除术的参与者都完成了研究。干预:在胰十二指肠切除术期间,利用吲哚菁绿评估胰腺残余的血液供应,捕捉不同的动脉、静脉和左静脉期,在给药10至15 s后分析。主要观察指标:在3例病例中,吲哚菁绿染色显示胰腺残端血管供应不均匀,在完成残端胰腺与空肠的吻合前需要调整边缘。结果:PPAP患者8例(18.6%),其中术后高淀粉酶血症5例(11.6%),B级PPAP 3例。结果显示,在40例灌注充足的患者中,7例发生PPAP(16.3%), 1例发生B级临床相关的术后胰瘘。相比之下,在3例灌注不足的患者中,胰缘翻修后,1例患者出现PPAP,均无临床相关的术后胰瘘。结论:术后急性胰腺炎,最终表现为术后胰瘘的可能性,必须警惕监测。虽然瘘的形成有多种因素,但使用吲哚菁绿确保胰腺残肢有足够的血管供应可能会减轻PPAP和相关并发症。该染料有助于提高胰十二指肠切除术后的手术效果。
{"title":"Role of indocyanine green to look for vascularity of the pancreatic stump during Whipple's procedure and its clinical implications in terms of post-pancreatectomy acute pancreatitis and postoperative pancreatic fistula.","authors":"Dhiresh Kumar Maharjan, Prabir Maharjan, Yugal Limbu, Roshan Ghimire, Prabin Bikram Thapa","doi":"10.1136/bmjsit-2024-000318","DOIUrl":"10.1136/bmjsit-2024-000318","url":null,"abstract":"<p><strong>Objectives: </strong>Post-pancreatectomy acute pancreatitis (PPAP) has been a well-defined entity by the International Study Group of Pancreatic Surgery. Underlying cause may be hypoperfusion at remnant stump of pancreas, which has been linked with additional post-pancreatectomy complications like postoperative pancreatic fistula. The primary goal was to assess the vascularity of remnant pancreas utilizing indocyanine green with near-infrared fluorescence. Indocyanine Green could aid in objectively mitigating hypoperfusion status of the pancreatic stump.</p><p><strong>Design: </strong>Hospital-based descriptive study conducted as per the revised Strengthening the Reporting of Observational Studies in Epidemiology guidelines between 1 August 2022 and 2 August 2023.</p><p><strong>Setting: </strong>This study was conducted in tertiary care centers of Kathmandu.</p><p><strong>Participants: </strong>All 43 participants who underwent pancreaticoduodenectomies were included who completed the study.</p><p><strong>Intervention: </strong>Blood supply to the remnant of the pancreas during pancreaticoduodenectomy was assessed utilizing indocyanine green, capturing distinct arterial, venous, and port venous phases, which were analyzed after 10 to 15 s of administration.</p><p><strong>Main outcome measures: </strong>In three instances, indocyanine green dye revealed unequal vascular supply at the pancreatic remnant, requiring adjustments to the margins before completing the anastomosis of the remnant pancreas and the jejunum.</p><p><strong>Results: </strong>PPAP was noticed in eight patients (18.6%), among which five patients (11.6 %) had postoperative hyperamylasemia, and three had grade B PPAP. The outcomes revealed that in the 40 patients with adequate perfusion, PPAP occurred in seven patients(16.3%), and grade B clinically relevant postoperative pancreatic fistula occurred in one patient. In contrast, among the three patients with inadequate perfusion, after revision of the pancreatic margin, PPAP was observed in one patient, and none of them had clinically relevant post-operative pancreatic fistula.</p><p><strong>Conclusion: </strong>Postoperative acute pancreatitis, ultimately exhibiting the possibility of postoperative pancreatic fistula, must be monitored with vigilance. While several elements contribute to fistula formation, ensuring sufficient vascular supply at the pancreatic remnant using indocyanine green may alleviate presumed PPAP and associated complications. The dye could aid in enhancing surgical outcomes following pancreaticoduodenectomy.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000318"},"PeriodicalIF":2.1,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12164612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144303021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic analysis of triclosan-coated versus uncoated sutures at preventing surgical site infection in patients undergoing abdominal surgery. 三氯生包被缝合线与未包被缝合线预防腹部手术患者手术部位感染的经济分析。
IF 2.1 Q2 SURGERY Pub Date : 2025-06-12 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2025-000383
Mwayi Kachapila, Dmitri Nepogodiev, Bryar Kadir, Maria Picciochi, Sivesh K Kamarajah, Aneel Bhangu, Raymond Oppong

Objectives: A recent meta-analysis of high-quality randomized trials casts doubt on the effectiveness of triclosan-coated sutures in reducing surgical site infection (SSI). This economic analysis is aimed at assessing whether triclosan-coated sutures, compared with uncoated sutures, can reduce costs from a healthcare perspective.

Design: This was a model-based economic analysis mainly informed by baseline SSI rates, effect size CIs from a recent meta-analysis of high-quality trials (OR 0.90, 95% CI 0.74 to 1.09, p=0.29), and country-specific cost data.

Setting: This was a worldwide analysis that estimated average cost savings aggregated for high, middle, and low Human Development Index (HDI) countries and country-specific cost savings for the 193 countries on the HDI list.

Participants: Participants were patients undergoing abdominal surgery. The analysis was informed by baseline SSI rates from an international cohort study (12 539 patients).

Main outcome measures: Results are reported in 2022 US dollars as average cost differences associated with SSI between coated and uncoated sutures. Deterministic sensitivity analyses examined variations in suture cost, hospital stay costs, and effect size, with best and worst-case scenario analyses.

Results: SSI-related cost differences per patient ranged from -$466 to $171 in high-HDI, -$23 to $18 in middle-HDI, and -$34 to $22 in low-HDI countries when triclosan-coated sutures were used. The largest potential savings and expenditure occurred in contaminated-dirty wounds. Similar results were observed at the national level in 184 of 193 countries. Best-case to worst-case analyses showed a range of -$533 to $192 in high-HDI, -$57 to $49 in middle-HDI and -$69 to $52 in low-HDI countries.

Conclusions: This analysis highlights significant uncertainty regarding cost savings with routine use of triclosan-coated sutures, emphasizing the need for high-quality data and CI-based economic analysis in policy making.

目的:最近一项高质量随机试验的荟萃分析对三氯生涂层缝合线减少手术部位感染(SSI)的有效性提出了质疑。本经济分析旨在评估三氯生涂层缝合线与未涂层缝合线相比,是否可以从医疗保健的角度降低成本。设计:这是一项基于模型的经济分析,主要依据基线SSI率、近期高质量试验荟萃分析的效应大小CI (OR 0.90, 95% CI 0.74至1.09,p=0.29)和国家特定成本数据。背景:这是一项全球范围的分析,估计了人类发展指数(HDI)高、中、低国家的平均成本节约总和,以及HDI名单上193个国家的具体国家成本节约。参与者:接受腹部手术的患者。该分析基于一项国际队列研究(12539例患者)的基线SSI率。主要结局指标:结果以2022美元报告,即涂层和未涂层缝合线与SSI相关的平均成本差异。确定性敏感性分析检查了缝合成本、住院成本和效应大小的变化,并进行了最佳和最坏情况分析。结果:当使用三氯生包覆缝线时,高hdi国家患者的ssi相关成本差异为- 466美元至171美元,中等hdi国家为- 23美元至18美元,低hdi国家为- 34美元至22美元。最大的潜在节省和支出发生在污染-肮脏伤口。在193个国家中,有184个国家也观察到了类似的结果。从最佳情况到最坏情况的分析显示,高hdi国家的消费范围为- 533美元至192美元,中等hdi国家为- 57美元至49美元,低hdi国家为- 69美元至52美元。结论:该分析强调了常规使用三氯生包覆缝线是否能节省成本的重大不确定性,强调了在制定政策时需要高质量的数据和基于ci的经济分析。
{"title":"Economic analysis of triclosan-coated versus uncoated sutures at preventing surgical site infection in patients undergoing abdominal surgery.","authors":"Mwayi Kachapila, Dmitri Nepogodiev, Bryar Kadir, Maria Picciochi, Sivesh K Kamarajah, Aneel Bhangu, Raymond Oppong","doi":"10.1136/bmjsit-2025-000383","DOIUrl":"10.1136/bmjsit-2025-000383","url":null,"abstract":"<p><strong>Objectives: </strong>A recent meta-analysis of high-quality randomized trials casts doubt on the effectiveness of triclosan-coated sutures in reducing surgical site infection (SSI). This economic analysis is aimed at assessing whether triclosan-coated sutures, compared with uncoated sutures, can reduce costs from a healthcare perspective.</p><p><strong>Design: </strong>This was a model-based economic analysis mainly informed by baseline SSI rates, effect size CIs from a recent meta-analysis of high-quality trials (OR 0.90, 95% CI 0.74 to 1.09, p=0.29), and country-specific cost data.</p><p><strong>Setting: </strong>This was a worldwide analysis that estimated average cost savings aggregated for high, middle, and low Human Development Index (HDI) countries and country-specific cost savings for the 193 countries on the HDI list.</p><p><strong>Participants: </strong>Participants were patients undergoing abdominal surgery. The analysis was informed by baseline SSI rates from an international cohort study (12 539 patients).</p><p><strong>Main outcome measures: </strong>Results are reported in 2022 US dollars as average cost differences associated with SSI between coated and uncoated sutures. Deterministic sensitivity analyses examined variations in suture cost, hospital stay costs, and effect size, with best and worst-case scenario analyses.</p><p><strong>Results: </strong>SSI-related cost differences per patient ranged from -$466 to $171 in high-HDI, -$23 to $18 in middle-HDI, and -$34 to $22 in low-HDI countries when triclosan-coated sutures were used. The largest potential savings and expenditure occurred in contaminated-dirty wounds. Similar results were observed at the national level in 184 of 193 countries. Best-case to worst-case analyses showed a range of -$533 to $192 in high-HDI, -$57 to $49 in middle-HDI and -$69 to $52 in low-HDI countries.</p><p><strong>Conclusions: </strong>This analysis highlights significant uncertainty regarding cost savings with routine use of triclosan-coated sutures, emphasizing the need for high-quality data and CI-based economic analysis in policy making.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000383"},"PeriodicalIF":2.1,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12164619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144303020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brightening the path to safe liver transplants: the role of ICG fluorescence in biliary anastomosis. 照亮安全肝移植的道路:ICG荧光在胆道吻合中的作用。
IF 2.1 Q2 SURGERY Pub Date : 2025-06-09 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2024-000322
Martín Huerta, Mar Dalmau, Nair Fernandes, Cristina Dopazo, Mireia Caralt, Laura Vidal, Ramón Charco, Itxarone Bilbao, Concepción Gómez-Gavara

Objectives: Evaluate the effectiveness of indocyanine green (ICG) fluorescence in enhancing the safety and precision of biliary anastomosis during liver transplantation (LT). The primary research question was whether ICG could provide real-time, objective assessment of bile duct vascularization to reduce postoperative biliary complications.

Design: Prospective, observational case series. IDEAL Stage 1 study.

Setting: Tertiary care academic medical center in Barcelona, Spain.

Participants: 10 adult patients who underwent LT between January 2023 and July 2024. Patients were selected based on the indication for LT with varying etiologies of liver failure. Donors included those with brain death and circulatory death (DCD).

Interventions: ICG was administered intravenously as a 3 mg bolus dose to evaluate the vascularization of the bile duct stumps. Fluorescence was visualized using a high-definition camera system during surgery, and adjustments to the anastomosis site were made based on the fluorescence patterns observed.

Main outcome measures: The primary outcome was the identification of non-vascularized (non-fluorescent) bile duct tissue and subsequent adjustments to the anastomosis site. Secondary outcomes included the incidence of biliary complications and patient survival during the follow-up period.

Results: ICG fluorescence successfully identified non-fluorescent areas in the bile duct stumps, leading to surgical adjustments in five cases (50%), particularly in DCD grafts. The procedure was well-tolerated with no adverse events related to ICG administration. The use of ICG fluorescence added an average of 3-5 min to the operative time. No biliary complications were reported during follow-up, and patient survival was 100%.

Conclusions: ICG fluorescence provides a valuable, objective tool for assessing bile duct vascularization during LT, potentially reducing biliary complications. This technique's integration into clinical practice could enhance surgical precision and improve patient outcomes. Further research is needed to confirm these findings in larger, more diverse populations.

目的:评价吲哚菁绿(ICG)荧光在肝移植手术中提高胆道吻合安全性和准确性的作用。主要的研究问题是ICG是否能够实时、客观地评估胆管血管形成情况,以减少术后胆道并发症。设计:前瞻性观察性病例系列。IDEAL一期研究。环境:西班牙巴塞罗那的三级医疗学术中心。参与者:2023年1月至2024年7月期间接受肝移植的10名成年患者。患者是根据肝衰竭不同病因的肝移植适应症来选择的。捐赠者包括脑死亡和循环死亡(DCD)患者。干预措施:ICG以3mg的剂量静脉注射,以评估胆管残端血管化。在手术过程中使用高清摄像系统观察荧光,并根据观察到的荧光模式对吻合部位进行调整。主要结局指标:主要结局是鉴定无血管化(非荧光)胆管组织和随后对吻合部位的调整。次要结局包括随访期间胆道并发症发生率和患者生存率。结果:ICG荧光成功地识别了胆管残端非荧光区域,导致5例(50%)的手术调整,特别是在DCD移植中。该手术耐受性良好,无与ICG相关的不良事件。ICG荧光的使用使手术时间平均延长3-5 min。随访期间无胆道并发症,生存率100%。结论:ICG荧光为肝移植过程中评估胆管血管形成提供了一种有价值的、客观的工具,可能减少胆道并发症。该技术与临床实践相结合,可提高手术精度,改善患者预后。需要进一步的研究在更大、更多样化的人群中证实这些发现。
{"title":"Brightening the path to safe liver transplants: the role of ICG fluorescence in biliary anastomosis.","authors":"Martín Huerta, Mar Dalmau, Nair Fernandes, Cristina Dopazo, Mireia Caralt, Laura Vidal, Ramón Charco, Itxarone Bilbao, Concepción Gómez-Gavara","doi":"10.1136/bmjsit-2024-000322","DOIUrl":"10.1136/bmjsit-2024-000322","url":null,"abstract":"<p><strong>Objectives: </strong>Evaluate the effectiveness of indocyanine green (ICG) fluorescence in enhancing the safety and precision of biliary anastomosis during liver transplantation (LT). The primary research question was whether ICG could provide real-time, objective assessment of bile duct vascularization to reduce postoperative biliary complications.</p><p><strong>Design: </strong>Prospective, observational case series. IDEAL Stage 1 study.</p><p><strong>Setting: </strong>Tertiary care academic medical center in Barcelona, Spain.</p><p><strong>Participants: </strong>10 adult patients who underwent LT between January 2023 and July 2024. Patients were selected based on the indication for LT with varying etiologies of liver failure. Donors included those with brain death and circulatory death (DCD).</p><p><strong>Interventions: </strong>ICG was administered intravenously as a 3 mg bolus dose to evaluate the vascularization of the bile duct stumps. Fluorescence was visualized using a high-definition camera system during surgery, and adjustments to the anastomosis site were made based on the fluorescence patterns observed.</p><p><strong>Main outcome measures: </strong>The primary outcome was the identification of non-vascularized (non-fluorescent) bile duct tissue and subsequent adjustments to the anastomosis site. Secondary outcomes included the incidence of biliary complications and patient survival during the follow-up period.</p><p><strong>Results: </strong>ICG fluorescence successfully identified non-fluorescent areas in the bile duct stumps, leading to surgical adjustments in five cases (50%), particularly in DCD grafts. The procedure was well-tolerated with no adverse events related to ICG administration. The use of ICG fluorescence added an average of 3-5 min to the operative time. No biliary complications were reported during follow-up, and patient survival was 100%.</p><p><strong>Conclusions: </strong>ICG fluorescence provides a valuable, objective tool for assessing bile duct vascularization during LT, potentially reducing biliary complications. This technique's integration into clinical practice could enhance surgical precision and improve patient outcomes. Further research is needed to confirm these findings in larger, more diverse populations.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000322"},"PeriodicalIF":2.1,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12163333/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144303019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with symptom-to-surgery time in patients undergoing surgical repair for acute type A aortic dissection: an exploratory analysis from a prospective cohort study. 急性A型主动脉夹层手术修复患者从症状到手术时间的相关因素:一项前瞻性队列研究的探索性分析
IF 2.1 Q2 SURGERY Pub Date : 2025-05-28 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2024-000304
Wilson Fandino, Tom Gilbey, Benjamin Milne, Joe Arrowsmith, Seema Agarwal, Matthew Dodd, Tim C Clayton, Gudrun Kunst

Abstract:

Objectives: The primary objective of this study was to investigate perioperative factors associated with symptom-to-surgery (STS) time in patients diagnosed with hyper-acute aortic dissection (AAD). The secondary objective was to develop a causal model to understand the relationship between STS times and hospital mortality in this population.

Design: Prospective cohort study.

Setting: Exploratory analysis of a national audit conducted by the Association of Cardiothoracic Anaesthesia and Critical Care.

Participants: From a total of 270 participants diagnosed with AAD with an STS time <72 hours, 218 were included in the multivariate analysis, after excluding 52 participants with missing covariates.

Main outcome measures: STS time, measured in hours. Hospital mortality at 30 days.

Results: In the multivariate analysis, mean STS time for misdiagnosed patients was nearly twice as high when compared with patients who initially had the correct diagnosis (estimated proportion of change=1.9, 95% CI 1.5 to 2.3, p<0.001). STS time decreased when patients were accompanied by a medical doctor in the ambulance transfer, had mean arterial blood pressure below 70 mm Hg or presented to the emergency department (ED) with a Glasgow Coma Scale (GCS) <15. Estimated ED-to-surgery (ETS) times were 1.8 hours longer for women than for men (10.5 hours, 95% CI 9.0 to 12.0 hours vs 8.7 hours, 95% CI 7.8 to 9.6 hours). From a total of 334 patients, 64 (19.2%) died. Mortality was higher in older patients and when STS time was ≥6 and <24 hours, compared with STS time <6 hours.

Conclusions: Potentially modifiable factors that may reduce STS times include avoidance of misdiagnosis and provision of a medical doctor for the ambulance transfer. Younger women had longer STS and ETS times, but further research is warranted to investigate the impact of age and sex on these times. The relationship between STS time and hospital mortality among these patients remains unclear.

摘要:目的:本研究的主要目的是探讨超急性主动脉夹层(AAD)患者围手术期与症状到手术(STS)时间相关的因素。次要目的是建立一个因果模型,以了解STS时间与该人群住院死亡率之间的关系。设计:前瞻性队列研究。背景:由心胸麻醉和危重症护理协会进行的国家审计的探索性分析。参与者:共270名诊断为AAD且STS时间的参与者。主要结果测量:STS时间,以小时计。30天住院死亡率结果:在多变量分析中,与最初诊断正确的患者相比,误诊患者的平均STS时间几乎是其两倍(估计变化比例=1.9,95% CI 1.5至2.3)。结论:可能减少STS时间的潜在可修改因素包括避免误诊和为救护车转移提供医生。年轻女性的STS和ETS时间较长,但需要进一步研究年龄和性别对这些时间的影响。这些患者的STS时间与住院死亡率之间的关系尚不清楚。
{"title":"Factors associated with symptom-to-surgery time in patients undergoing surgical repair for acute type A aortic dissection: an exploratory analysis from a prospective cohort study.","authors":"Wilson Fandino, Tom Gilbey, Benjamin Milne, Joe Arrowsmith, Seema Agarwal, Matthew Dodd, Tim C Clayton, Gudrun Kunst","doi":"10.1136/bmjsit-2024-000304","DOIUrl":"10.1136/bmjsit-2024-000304","url":null,"abstract":"<p><strong>Abstract: </strong></p><p><strong>Objectives: </strong>The primary objective of this study was to investigate perioperative factors associated with symptom-to-surgery (STS) time in patients diagnosed with hyper-acute aortic dissection (AAD). The secondary objective was to develop a causal model to understand the relationship between STS times and hospital mortality in this population.</p><p><strong>Design: </strong>Prospective cohort study.</p><p><strong>Setting: </strong>Exploratory analysis of a national audit conducted by the Association of Cardiothoracic Anaesthesia and Critical Care.</p><p><strong>Participants: </strong>From a total of 270 participants diagnosed with AAD with an STS time <72 hours, 218 were included in the multivariate analysis, after excluding 52 participants with missing covariates.</p><p><strong>Main outcome measures: </strong>STS time, measured in hours. Hospital mortality at 30 days.</p><p><strong>Results: </strong>In the multivariate analysis, mean STS time for misdiagnosed patients was nearly twice as high when compared with patients who initially had the correct diagnosis (estimated proportion of change=1.9, 95% CI 1.5 to 2.3, p<0.001). STS time decreased when patients were accompanied by a medical doctor in the ambulance transfer, had mean arterial blood pressure below 70 mm Hg or presented to the emergency department (ED) with a Glasgow Coma Scale (GCS) <15. Estimated ED-to-surgery (ETS) times were 1.8 hours longer for women than for men (10.5 hours, 95% CI 9.0 to 12.0 hours vs 8.7 hours, 95% CI 7.8 to 9.6 hours). From a total of 334 patients, 64 (19.2%) died. Mortality was higher in older patients and when STS time was ≥6 and <24 hours, compared with STS time <6 hours.</p><p><strong>Conclusions: </strong>Potentially modifiable factors that may reduce STS times include avoidance of misdiagnosis and provision of a medical doctor for the ambulance transfer. Younger women had longer STS and ETS times, but further research is warranted to investigate the impact of age and sex on these times. The relationship between STS time and hospital mortality among these patients remains unclear.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000304"},"PeriodicalIF":2.1,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12121560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144209692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ending nuclear weapons, before they end us. 在核武器终结我们之前终结它们。
IF 2.1 Q2 SURGERY Pub Date : 2025-05-15 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2025-000412
Chris Zielinski
{"title":"Ending nuclear weapons, before they end us.","authors":"Chris Zielinski","doi":"10.1136/bmjsit-2025-000412","DOIUrl":"10.1136/bmjsit-2025-000412","url":null,"abstract":"","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000412"},"PeriodicalIF":2.1,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12083298/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing an innovative interventional approach for stenting trachea. 开发一种创新的气管支架介入方法。
IF 2.1 Q2 SURGERY Pub Date : 2025-05-08 eCollection Date: 2025-01-01 DOI: 10.1136/bmjsit-2022-000180
Maryam Mazraehei Farahani, Abdol-Mohammad Kajbafzadeh, Arda Kiani, Hossein Kazemizadeh, Mostafa Baghani

Objectives: Stenting is a method of controlling airway occlusions (CAO) that can be used alone or in combination with other treatments. There are different types of airway stents. One of the most widely used types is silicone stent. These stents are flexible and firm enough cylinders inserted into the airway by a rigid scope to relieve dyspnoea caused by CAO in malignant and non-malignant diseases. We have developed a method that can be applied quickly in remote urgent cases without a rigid scope.

Design: We used two endotracheal tubes with a size of 8.5 for stenting.

Setting: This research was conducted at Pediatric Urology and Regenerative Medicine Research Center, Children's Medical Center, Pediatric Center of Excellence, Animal Lab Tehran University of Medical Sciences, Tehran, Iran (IR).

Participants instead of patients or subjects: Two certified mature sheep (ewes).

Interventions: Silicone stent placement for 2 months.

Main outcome measures: A method with minimal facilities for stenting without limitation of trachea size.

Results: A pilot animal study has been performed on two mature certified sheep to test a stenting procedure. Stenting procedures have been successfully implemented on the animals' trachea.

Conclusions: We have developed a new simple, fast and cheap procedure for stenting silicon stents with minimum risk. We can easily place and rotate the stent during the procedure.

目的:支架植入术是一种控制气道闭塞(CAO)的方法,可以单独使用,也可以与其他治疗方法联合使用。有不同类型的气道支架。硅胶支架是应用最广泛的一种。这些支架是足够灵活和坚固的圆柱体,通过刚性范围插入气道,以缓解恶性和非恶性疾病中由CAO引起的呼吸困难。我们已经开发了一种方法,可以快速应用于远程紧急情况下,没有严格的范围。设计:我们使用两根8.5尺寸的气管内导管进行支架置入。环境:本研究在伊朗德黑兰医科大学动物实验室,儿童医学中心,儿科泌尿学和再生医学研究中心进行。参与者(而不是患者或受试者):两只经过认证的成熟绵羊(母羊)。干预措施:硅胶支架放置2个月。主要观察指标:一种不受气管大小限制、设备最少的支架置入方法。结果:一项实验性动物研究已经在两只经过认证的成熟绵羊身上进行,以测试支架植入程序。在动物的气管上成功地实施了支架植入手术。结论:我们开发了一种简单、快速、廉价、风险最小的硅片支架植入新方法。在手术过程中我们可以很容易地放置和旋转支架。
{"title":"Developing an innovative interventional approach for stenting trachea.","authors":"Maryam Mazraehei Farahani, Abdol-Mohammad Kajbafzadeh, Arda Kiani, Hossein Kazemizadeh, Mostafa Baghani","doi":"10.1136/bmjsit-2022-000180","DOIUrl":"10.1136/bmjsit-2022-000180","url":null,"abstract":"<p><strong>Objectives: </strong>Stenting is a method of controlling airway occlusions (CAO) that can be used alone or in combination with other treatments. There are different types of airway stents. One of the most widely used types is silicone stent. These stents are flexible and firm enough cylinders inserted into the airway by a rigid scope to relieve dyspnoea caused by CAO in malignant and non-malignant diseases. We have developed a method that can be applied quickly in remote urgent cases without a rigid scope.</p><p><strong>Design: </strong>We used two endotracheal tubes with a size of 8.5 for stenting.</p><p><strong>Setting: </strong>This research was conducted at Pediatric Urology and Regenerative Medicine Research Center, Children's Medical Center, Pediatric Center of Excellence, Animal Lab Tehran University of Medical Sciences, Tehran, Iran (IR).</p><p><strong>Participants instead of patients or subjects: </strong>Two certified mature sheep (ewes).</p><p><strong>Interventions: </strong>Silicone stent placement for 2 months.</p><p><strong>Main outcome measures: </strong>A method with minimal facilities for stenting without limitation of trachea size.</p><p><strong>Results: </strong>A pilot animal study has been performed on two mature certified sheep to test a stenting procedure. Stenting procedures have been successfully implemented on the animals' trachea.</p><p><strong>Conclusions: </strong>We have developed a new simple, fast and cheap procedure for stenting silicon stents with minimum risk. We can easily place and rotate the stent during the procedure.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"7 1","pages":"e000180"},"PeriodicalIF":2.1,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMJ Surgery Interventions Health Technologies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1